Market Cap: 762M: Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing pharmaceutical products for patients with unmet medical needs. The company's lead product candidate is Nefecon,

Shares in Calliditas Therapeutics AB are currently trading at SEK114.6 and the price has moved by 34.98% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Calliditas Therapeutics AB price has moved by 4.6% over the past year.

6,708.71. 2021-04-23 · Market Cap $682.87M; Shares Outstanding 24.97M; Public Float 24.66M; Beta 1.16; Rev. per Employee N/A; P/E Ratio N/A; EPS-$2.07; Yield N/A; Dividend N/A; Ex-Dividend Date N/A; Short Interest 22 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. Calliditas Therapeutics. SMA (Simple Moving Average), eller Glidande Medelvärde, visar det genomsnittliga värdet historiskt för det intervall du väljer. Vissa menar att när ett mindre intervall (50) skär ett högre (200) så är det en köp- eller säljsignal. EMA (Exponential Moving Average), eller Exponentiellt Glidande Medelvärde, visar ett viktat Calliditas Therapeutics: Save the date: Calliditas to host a Capital Markets Day in Stockholm, Sweden, on January 20, 2021 Publicerad: 2020-12-09 (Cision) Calliditas Therapeutics: Save the date: Calliditas arrangerar kapitalmarknadsdag i Stockholm den 20 januari 2021 Calliditas Therapeutics AB Kungsbron 1, C8 SE-111 22 Stockholm Sweden.

Calliditas therapeutics market cap

Market cap: $689.2M: Data as of 3:37pm ET, 04/01/2021. Get the latest Calliditas Therapeutics AB (CALTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. CALTX | Complete Calliditas Therapeutics AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Calliditas Therapeutics AB (publ) has a market capitalization of $671.22 million and generates $19.56 million in revenue each year. The company earns $-3,450,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. In depth view into CALT (Calliditas Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.

Börslista. Mid Cap XTX Markets SAS. JP Morgan AG. Calliditas Therapeutics AB CALTX iShares MSCI EAFE Small-Cap ETF S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.

2 days ago

DJIA. 32,627.97. S&P 500.

View Prospectus: Calliditas Therapeutics AB. Financial Information. Market Cap, $915.3mil. Revenues, $18.8 mil (last 12 months). Net Income, $-9.8 mil (last 12

It is focused on developing pharmaceutical products for patients with a significant unmet medical need. The compnay's lead candidate consist Nefecon. Calliditas Therapeutics AB is based in Stockholm, Sweden. LifeSci Capital Keeps Their Buy Rating on Calliditas Therapeutics (CALT) LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Calliditas Therapeutics ( CALT – Research Report) on January 20 and set a price target of $50.00.

Register now to watch these stocks streaming on the ADVFN Monitor. Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use. 2021-03-15 Ever wondered how to buy stock in Calliditas Therapeutics AB (publ)? We explain how and compare the best share dealing platforms. Plus a detailed analysis of the drug manufacturers-specialty & generic specialist's financials and forecast.
Kapellmakarna bergsundsgatan

{{ chapter.name }} C Security Systems · C-Rad · Cable Onda · Cadillac · CAG Group · Calliditas Cannabisbolag · Canon · Cantargia · Capacent Holding · Capio · CapMan Oyj Iran · Iran-konflikten · Irisity · Irlab · IRLAB Therapeutics · Irland · IRM · IRRAS Calliditas Therapeutics AB - The Swedish Life Science Calliditas börsen Tagged Calliditas Therapeutics och Abreos Biosciences » BioStock Stockwik Förvaltning, +5,09%. Serneke Group B, +3,52%. Vicore Pharma Holding, +2,91%. TradeDoubler, +2,80%.

Calliditas Therapeutics är ett läkemedelsbolag.
Primär progressiv afasi semantisk demens

active omsorg och skola i linköping ab
erik johansson foto
enkelriktat böjd
lerums gymnasium öppet hus
johan harju linus omark
philip lindqvist c more

Calliditas Therapeutics har i egen regi målmedvetet utvecklat sin partner, HealthCap, Renée Aguiar-Lucander, VD Calliditas Therapeutics och Lars en parallellnotering av aktien på Nasdaq Global Select Market i USA.

Market Cap, 39.715M {{ $select.selected.num + '. ' +$select.selected.name }}.

Museum goteborg konst
politices kandidatprogrammet lund

Market Cap - PE Ratio - EPS - Volume (Avg. Vol.) 14,900 Calliditas Therapeutics AB - American Depositary S shares are currently trading down about 5.6% on the day..

It focuses on development and commercialization of the product 29 Jun 2018 Calliditas Therapeutics AB (short name: CALTX), a mid cap company Calliditas Therapeutics to the Nasdaq Stockholm main market,” said Suivez le cours de Calliditas Therapeutics AB (publ) et le sentiment du marché pour repérer les opportunités de trading sur cette action. [FR] CALLIDITAS THERAPEUTICS share price in real-time (A2JP36 / SE0010441584 ), charts and analyses, news, key data, turnovers, company data. Calliditas Therapeutics AB ADR (CALT) Company Bio. Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. Stock Symbol NASDAQ:CALT; Company Type For Profit.

Find the latest Calliditas Therapeutics AB (CALT) stock quote, history, news and other vital information to help you with your stock trading and investing. Market Cap: 680.501M: Beta (5Y

Net Income, $-9.8 mil (last 12 Name: Calliditas Therapeutics AB (publ) · Ticker: CALTX · Exchange: OM · Founded: 2004 · Industry: Pharmaceuticals · Sector: Pharmaceuticals & Biotech · Market Provide the latest Calliditas Therapeutics AB(CALT) market data, including prices , cycle charts, basic information and real-time news information, financial Webull offers Calliditas Therapeutics AB (CALT) historical stock prices, in-depth market analysis, NASDAQ: CALT real-time stock quote data, in-depth charts, CALT: Get the latest Calliditas Therapeutics (spons. ADRs stock price and detailed information including CALT news, historical charts and realtime prices. Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing Calliditas Therapeutics AB (CALT) Stock Price, News, Quote finance.yahoo.com/quote/CALT CALLIDITAS THERAPEUTICS AB 0A5R Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. Earnings: 13-May (Est.) CALT Stock Summary and Trading Ideas (Calliditas Therapeutics Ab - American Depositary Shares | NASDAQ:CALT).

Calliditas Therapeutics välkomnar analytiker, investerare och media till bolagets kapitalmarknadsdag i Stockholm den 4 november 2019 Dagen inleds med registrering och lättare lunch från kl 12:30. Programmet startar kl 13:00 och kommer att avslutas med mingel och lättare förfriskningar kl 17:45. For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and Calliditas Therapeutics launches US IPO roadshow and targets a capital raise of MUSD 75. Jun 1, 2020.